The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the 10 Stocks With Easy 9-30% Upside.

Ocular Therapeutix rallied for a third straight session on Thursday, jumping 10.45 percent to close at $9.30 apiece, as investors continued to load up portfolios in anticipation of business updates from its participation in several conferences next week.

Chief Scientific Officer Jeffrey Heier and Chief Development Officer Peter Kaiser are set to present in a symposium at the 14th Annual Vit-Buckle Society (VBS) Meeting in Las Vegas, Nevada, on Saturday, April 11, Ocular Therapeutix Inc. (NASDAQ:OCUL) said. They are expected to discuss redefining the management of Neovascular AMD.

Photo by José Antonio Otegui Auzmendi on Pexels

Likewise, its Chairman, President, and CEO, Pravin Dugel, would present at the Congreso Nacional de Oftalmologia (CNO) 2026 in Buenos Aires, Argentina, next Wednesday, April 15, where he would tackle Tyrosine Kinase Inhibitors, as well as the current state of treatments for diabetic retinal disease and neovascular AMD.

Investors expect Ocular Therapeutix Inc. (NASDAQ:OCUL) to provide updates from its investigational drug, Axpaxli, which is currently being studied in a phase 3 trial for patients with wet age-related macular degeneration (wet AMD) and diabetic retinal disease, including non-proliferative diabetic retinopathy (NPDR).

While we acknowledge the potential of OCUL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.